CATT (Lucentis-Avastin Trial)

Status: Completed

ClinicalTrials.gov Identifier: NCT00593450

CATT: Comparison Study of Lucentis versus Avastin in patients with wet AMD.

Condition: Age-Related Macular Degeneration

Study Type: Interventional

Duration: 7 years and 2 months

Eligibility:

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.